VT News

Brayden Ainsworth

Ask VT AI
View News Summary
  • Fed cuts rates amid economic uncertainty, signaling flexibility to adjust policy as needed.
  • Dexcom shares plunge after cautious 2026 outlook, despite strong Q3 results, as analysts cite margin pressure and uncertainty around G7 sensor uptake and accuracy.
  • Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Fed cuts rates amid economic uncertainty, signaling flexibility to adjust policy as needed.
  • Dexcom shares plunge after cautious 2026 outlook, despite strong Q3 results, as analysts cite margin pressure and uncertainty around G7 sensor uptake and accuracy.
  • Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Brayden Ainsworth

Top Topics

Trending in U.S.

World

Sport